Skip to the page

Data / Form D filings / INTERPACE BIOSCIENCES, INC.

INTERPACE BIOSCIENCES, INC.: Form D filings

INTERPACE BIOSCIENCES, INC., a health care company in Parsippany, NJ, filed 5 Form D notices with the SEC between 2017 and 2024. The latest, on October 16, 2024, reports $47 million sold of a $47 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
WATERVIEW PLAZA, SUITE 310, 2001 ROUTE 46, Parsippany, NJ, 07054
Phone
(855) 776-6419
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1054102

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 16, 2024New notice$47,000,000$47,000,0002Oct 11, 2024sec.gov
Jan 27, 2020New notice$47,000,000$47,000,0002Jan 10, 2020sec.gov
Jul 29, 2019New notice$27,000,000$14,000,000$13,000,0001Jul 15, 2019sec.gov
Oct 16, 2017New notice$5,000,000$5,000,0004Oct 12, 2017sec.gov
Jan 27, 2017New notice$4,121,100$111,150$4,009,9506Jan 20, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephen J. SullivanDirector
Vijay W. AggarwalDirector
Joseph W. KeeganDirector
Fortunato W. Ron RoccaDirector
Christopher W. McCarthyExecutive Officer
Thomas W. BurnellExecutive Officer, Director

Other health care companies in New Jersey that filed recently

Every Form D from the week of Oct 14, 2024 · All recent filings in New Jersey · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what INTERPACE BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.